Intraocular Pressure Effects of Pegaptanib (Macugen) Injections in Patients With and Without Glaucoma

To link to full-text access for this article, visit this link: http://dx.doi.org/10.1016/j.ajo.2007.01.052 Byline: Ronald E.P. Frenkel (a)(b), Lakshmi Mani (a), Allison R. Toler (a)(b), Max P.C. Frenkel (a) Abstract: To determine if pegaptanib (Macugen) [Eyetech Pharmaceuticals; Pfizer Inc, New York, New York, USA] injections cause adverse intraocular pressure (IOP) effects in patients with and without glaucoma. Author Affiliation: (a) Eye Research Foundation, Stuart, Florida (b) East Florida Eye Institute, Stuart, Florida. Article History: Accepted 26 January 2007